Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Chirurgia (Bucur) ; 111(2): 170-4, 2016.
Article in English | MEDLINE | ID: mdl-27172533

ABSTRACT

INTRODUCTION: Paragangliomas are rare neuroendocrine tumors that arise from the extra-adrenal autonomic paraganglia, which can derive from either parasympathetic or sympathetic paraganglia and are closely related to pheochromocytomas. CASE REPORT: We present the case of a young male patient of 37 years old, who was admitted for hypertensive crisis and palpitations. His medical history included medically controlled type 2 diabetes mellitus, (diagnosed 10 months ago), Hepatitis A. Hormonal evaluation revealed elevated urinary metanephrines and normetanephrines, with mainly increased normetanephrines (2330 ug/24 h). Plasmatic metanephrins were in normal range, but levels of plasmatic normetanephrins were elevated (952 pg/ml). The assessment of pituitary and aldosterone-renin axis values were within normal limits. Abdominal computed tomography showed left adrenal nodular lesion on the external arm, bilobulated, size 32/33 mm with maximum axial and cranio-caudal diameter of approx. 45 cm, suggestive of a benign lesion, keeping the cleavage plane to vecinatate structures. Left adrenalectomy was performed by laparoscopic approach. We mention that immediately after induction of anesthesia were recorded blood pressures of 298/143 mmHg. Histopathologic and immunohistochemical examination diagnose paraganglioma, without invasion of adjacent tissues. The patient evolution was favorable, with the remission of the symptoms and normalization of hormonal markers. It is imperative to note the remission of diabetes in the postoperative period. DISCUSSION: This is the case of a young patient with functional retroperitoneal paraganglioma, who presented with symptoms of pheochromocytoma. Compared to pheochromocytomas, paragangliomas are rarely symptomatic and functional. Association with diabetes is even more rare. Specialized investigations allowed the proper diagnosis and the therapeutic approach above was the result of a multidisciplinary cooperation.


Subject(s)
Diabetes Mellitus, Type 2/etiology , Paraganglioma, Extra-Adrenal/complications , Paraganglioma, Extra-Adrenal/diagnosis , Retroperitoneal Neoplasms/complications , Retroperitoneal Neoplasms/diagnosis , Adrenalectomy , Adult , Biomarkers, Tumor/blood , Biomarkers, Tumor/urine , Diagnosis, Differential , Humans , Hypertension/etiology , Male , Metanephrine/blood , Metanephrine/urine , Normetanephrine/blood , Normetanephrine/urine , Paraganglioma, Extra-Adrenal/blood , Paraganglioma, Extra-Adrenal/surgery , Paraganglioma, Extra-Adrenal/urine , Rare Diseases , Retroperitoneal Neoplasms/blood , Retroperitoneal Neoplasms/surgery , Retroperitoneal Neoplasms/urine , Treatment Outcome
3.
BMC Res Notes ; 6: 331, 2013 Aug 19.
Article in English | MEDLINE | ID: mdl-23958171

ABSTRACT

BACKGROUND: Adrenocorticotropic hormone-producing extraadrenal paragangliomas are extremely rare. We present a case of severe hypercortisolemia due to ectopic adrenocorticotropic hormone secretion by a nasal paraganglioma. CASE PRESENTATION: A 70-year-old Caucasian woman, was emergently admitted to our department with supraventricular tachycardia, oedema of face and extremities and hypertensive crisis. Initial laboratory evaluation revealed severe hypokalemia and hyperglycemia without ketoacidosis, although no diabetes mellitus was previously known. Computed tomography revealed a large tumor obliterating the left paranasal sinus and a left-sided adrenal mass. After cardiovascular stabilisation, a thorough hormonal assessment was performed revealing marked adrenocorticotropic hormone-dependent hypercortisolism. Due to the presence of a cardiac pacemaker magnetic resonance imaging of the hypophysis was not possible. [68Ga-DOTA]-TATE-Positron-Emission-Tomography was performed, showing somatostatin-receptor expression of the paranasal lesion but not of the adrenal lesion or the hypophysis. The paranasal tumor was resected and found to be an adrenocorticotropic hormone-producing paraganglioma of low-proliferative rate. Postoperatively the patient became normokaliaemic, normoglycemic and normotensive without further need for medication. Genetic testing showed no mutation of the succinatdehydrogenase subunit B- and D genes, thus excluding hereditary paragangliosis. CONCLUSION: Detection of the adrenocorticotropic hormone source in Cushing's syndrome can prove extremely challenging, especially when commonly used imaging modalities are unavailable or inconclusive. The present case was further complicated by the simultaneous detection of two tumorous lesions of initially unclear biochemical behaviour. In such cases, novel diagnostic tools - such as somatostatin-receptor imaging - can prove useful in localising hormonally active neuroendocrine tissue. The clinical aspects of the case are discussed and relevant literature is reviewed.


Subject(s)
ACTH Syndrome, Ectopic/etiology , Adrenocorticotropic Hormone/blood , Cushing Syndrome/etiology , Hydrocortisone/blood , Nose Neoplasms/complications , Paraganglioma, Extra-Adrenal/complications , ACTH Syndrome, Ectopic/blood , ACTH Syndrome, Ectopic/diagnosis , ACTH Syndrome, Ectopic/therapy , Adrenocorticotropic Hormone/metabolism , Aged , Biomarkers/blood , Cushing Syndrome/blood , Cushing Syndrome/diagnosis , Cushing Syndrome/therapy , Female , Humans , Nose Neoplasms/blood , Nose Neoplasms/diagnosis , Nose Neoplasms/metabolism , Nose Neoplasms/surgery , Organometallic Compounds , Paraganglioma, Extra-Adrenal/blood , Paraganglioma, Extra-Adrenal/diagnosis , Paraganglioma, Extra-Adrenal/metabolism , Paraganglioma, Extra-Adrenal/surgery , Positron-Emission Tomography , Radiopharmaceuticals , Severity of Illness Index , Tomography, X-Ray Computed , Treatment Outcome
4.
Endocrinol Metab Clin North Am ; 40(2): 295-311, vii, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21565668

ABSTRACT

Pheochromocytoma is a tumor of the chromaffin cells in the adrenal medulla and sympathetic paraganglia, which synthesizes and secretes catecholamines. Norepinephrine, epinephrine, and dopamine all act on their target receptors, which causes a physiologic change in the body. High circulating levels of catecholamines can lead to severe hypertension and can have devastating effects on multiple body systems (eg, cardiovascular, cerebrovascular), and can lead to death if untreated. Although surgical treatment represents the only modality of ultimate cure, pharmacologic preoperative treatment remains the mainstay of successful outcome.


Subject(s)
Adrenal Gland Neoplasms/physiopathology , Hypertension/etiology , Pheochromocytoma/physiopathology , Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/drug therapy , Adrenal Gland Neoplasms/metabolism , Adult , Child , Dopamine/blood , Dopamine/metabolism , Epinephrine/blood , Epinephrine/metabolism , Humans , Norepinephrine/blood , Norepinephrine/metabolism , Paraganglioma, Extra-Adrenal/blood , Paraganglioma, Extra-Adrenal/metabolism , Paraganglioma, Extra-Adrenal/physiopathology , Pheochromocytoma/diagnosis , Pheochromocytoma/drug therapy , Pheochromocytoma/metabolism
5.
Cancer ; 70(9): 2350-3, 1992 Nov 01.
Article in English | MEDLINE | ID: mdl-1327496

ABSTRACT

A patient with a malignant extraadrenal retroperitoneal paraganglioma had elevated levels of immunoreactive neuropeptide Y (NPY) in the peripheral blood (5988 pg/ml; normal, 123 +/- 30 pg/ml [mean +/- standard error of the mean]). A 6-month course of chemotherapy allowed surgical removal of the previously unresectable primary tumor. Postoperatively, the plasma NPY level initially fell to 1089 pg/ml; continued chemotherapy caused an additional decrease to 440 pg/ml. Four months after surgery, the plasma NPY level increased to 940 mg/ml, coincident with hepatic metastases. This case is the first report of a NPY-secreting clinically nonfunctional malignant extraadrenal paraganglioma. Determination of circulating NPY levels may be useful in the diagnosis and follow-up of patients with neuroendocrine tumors.


Subject(s)
Neuropeptide Y/blood , Paraganglioma, Extra-Adrenal/blood , Retroperitoneal Neoplasms/blood , Female , Humans , Middle Aged , Neoplasm Invasiveness , Neuropeptide Y/metabolism , Paraganglioma, Extra-Adrenal/metabolism , Paraganglioma, Extra-Adrenal/pathology , Paraganglioma, Extra-Adrenal/secondary , Peritoneal Neoplasms/secondary , Retroperitoneal Neoplasms/metabolism , Retroperitoneal Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...